The theme of the proposed Alzheimer Disease Research Center will be the study of familial dementia of the Alzheimer type (DAT). Funding or partial funding is requesting for 7 Cores (Administrative; Training and Information Transfer; Research Support and Clinical Data File; General Autopsy and Neuropathology Service; Cell Tissue and Fluids Bank/Cell Culture/Cytogenetics; Monoclonal Antibodies Lab; Feasibility Studies) and three new research projects (Linkage Analysis in Familial DAT; Somatic Cell Investigation of Neurodegenerative Disorders; DNA Damage in DAT). An eighth Core (Non-Human Primates) receives independent funding. A ninth Core (Neuroimaging) is likely to be developed by yr. 03. The long term goals of the thematic research are to identify and characterize major genes associated with forms of DAT consistent with autosomal dominant modes of inheritance and to elucidate the nature of the gene action at the molecular, cellular and clinical levels. The ADRC and its Cores are also designed to facilitate new lines of research on DAT by funded investigators active in highly relevant fields (eg., neurotoxicology; neurobiology of hippocampus; chemistry of structural proteins; cytogenetics; molecular virology; amyloidosis) and to enhance the education of professionals and the public on the nature of DAT and related neurodegenerative disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005136-04
Application #
3104762
Study Section
Aging Review Committee (AGE)
Project Start
1985-09-30
Project End
1990-09-29
Budget Start
1988-05-01
Budget End
1989-04-30
Support Year
4
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Nafikov, Rafael A; Nato Jr, Alejandro Q; Sohi, Harkirat et al. (2018) Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP. Genet Epidemiol 42:500-515
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Davis, Jeremy J (2018) Performance validity in older adults: Observed versus predicted false positive rates in relation to number of tests administered. J Clin Exp Neuropsychol 40:1013-1021
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Young, Jessica E; Fong, Lauren K; Frankowski, Harald et al. (2018) Stabilizing the Retromer Complex in a Human Stem Cell Model of Alzheimer's Disease Reduces TAU Phosphorylation Independently of Amyloid Precursor Protein. Stem Cell Reports 10:1046-1058
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Wang, Lucy Y; Raskind, Murray A; Wilkinson, Charles W et al. (2018) Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia. Int J Geriatr Psychiatry 33:763-768
Moreno, Monica A; Or-Geva, Noga; Aftab, Blake T et al. (2018) Molecular signature of Epstein-Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466

Showing the most recent 10 out of 753 publications